Skip to main content

Swiss Chinese Life Science Forum (EN)

SCLSF Banner NEW

A whole new game? – Innovation and Regulation in China and Switzerland

We cordially invite you to participate in the online Swiss Chinese Life Sciences Forum, which will be held on March 16, 2022. The forum is co-organized in collaboration of SCCC, Basel Area Business & Innovation and VISCHER AG.

Switzerland is home to a highly innovative life science cluster. Many multinational corporations, as well as a network of smaller companies and startups have operations in Switzerland, mostly in the Basel Area. The industry is vibrant, with many innovative developments occurring in pharmaceuticals, biotech or digital health.

In China, the life science industry has been growing at an accelerated pace in the last few years and at the same time China is moving towards becoming the largest pharmaceutical market in the world.

Both, Swiss and Chinese companies have a lot to gain from innovation and international expansion.

During this year’s Swiss Chinese Life Sciences Forum, we will address current key issues in the industry. Guest speakers from Swiss as well as Chinese companies will present insights into the following topics:

  • Ways to set up operations in Switzerland to access the European market
  • Innovation at startups
  • Macro-economic trends in the life science industry and regulatory developments
  • Strengthening Sino-Swiss collaboration

We are looking forward to welcoming you at this year’s Life Sciences Forum!

Program

09:30

Welcome
Beilun Wei, General Manager, Swiss Chinese Chamber of Commerce
Christian Wyss, Partner, VISCHER
Anke Hollnagel, Director Asia, Basel Area Business & Innovation

09:35

Introduction of panelists
Gabriel Schweizer, Moderator

09:40

Cancer has no borders! BeiGene’s way from Beijing to Basel and a global organization
Nils Eckardt, Vice President Medical Affairs Europe, BeiGene

09:55

From Europe to China and back – How WORG Pharmaceutical leverages the best of both worlds
Rainer Henning, Chief Scientific Officer and Head of European Operations, Worg Pharm

10:10

Game changing innovation- HK Biorhythm’s technology and strategy for internationalization
Julia Liu, CEO & Co-founder, HK Bio-Rhythm R&D Company

10:25

Panel discussion with speakers from first session

10:40

Coffee break

10:55

Introduction of panelists
Gabriel Schweizer, Moderator

11:00

Is the Chinese biotech industry overheated?  Macroeconomic trends in the life sciences industry
Petra Jantzer, Senior Managing Director, Accenture

11:15

Entering the Chinese pharmaceutical market – requirements for marketing authorization holders
Marylène Zhan, Senior RA Consultant, Accestra

11:30

Accelerating China’s Healthcare Innovation to Benefit the World
Qiusong Tang, Head of Roche Accelerator, Roche

11:45

Panel discussion with speakers from second session

12:00

Closing
Beilun Wei, General Manager, Swiss Chinese Chamber of Commerce
Christian Wyss, Partner, VISCHER
Anke Hollnagel, Director Asia, Basel Area Business & Innovation

Participation is free, however registration is required before March 15th, 2022

Our partners